Operating Lease, Right-of-Use Asset of Pasithea Therapeutics Corp. from 30 Jun 2022 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Pasithea Therapeutics Corp. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2022 to 31 Mar 2024.
  • Pasithea Therapeutics Corp. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2024 was $32,026, a 93% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Pasithea Therapeutics Corp. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $32,026 -$428,513 -93% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $79,271 -$421,157 -84% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 $378,453 -$553,511 -59% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $419,885 +$9,493 +2.3% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $460,539 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $500,428 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 $931,964 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $410,392 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.